By Peter Loftus and Gregory Zuckerman July 1, 2020 10:53 am ET At the year’s start, few outside the world of biotech had heard of a Boston-area company with a New Age name and unproven approach to drugmaking. Most in the industry who did know Moderna Inc. MRNA -3.39% doubted its prospects. Investors barely had interest in the company, which […]
Archive for August, 2020
Hedge Fund Star John Paulson Calls It Quits
By Gregory Zuckerman July 1, 2020 5:09 pm ET John Paulson made billions of dollars anticipating the 2008 financial collapse. But after running into difficulties in recent years, Mr. Paulson will convert his hedge fund firm into a private investment firm that runs only his family’s money. Mr. Paulson’s decision to hand his investors’ their […]
With Biotech Stocks, Investors Love the Thrill of the Chase
By Gregory Zuckerman and Michael Wursthorn Aug. 5, 2020 5:30 am ET Eric Distenfeld is rolling the dice on CytoDyn Inc. Last month, the real-estate executive bought 1,000 shares of the unheralded biotech company, which hopes to discover a Covid-19 drug. Now, he spends the day tracking shares, checking news and debating friends whether CytoDyn can […]
